# Assessment of Salbutamol Effect on Arterial Oxygenation in COPD Patients During One-lung Ventilation

> **NCT05914285** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Yonsei University** · enrollment: 90 (actual)

## Conditions studied

- One-lung Ventilation
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** 5ml of inhaled normal saline
- **DRUG:** 2.5mg (2.5ml) of inhaled salbutamol and 2.5ml of inhaled normal saline

## Key facts

- **NCT ID:** NCT05914285
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-25
- **Primary completion:** 2025-06-20
- **Final completion:** 2025-07-21
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05914285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05914285, "Assessment of Salbutamol Effect on Arterial Oxygenation in COPD Patients During One-lung Ventilation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05914285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*